Unlocking The Secrets Of DNA And First View Of DNA Damage Within Entire Human...Isabella Cano
Neutron scattering can provide information about the correlation between DNA base pairs during denaturation, which is not possible using other techniques. The experiment measured the first stage of the melting transition where DNA strands separate as the bonds between base pairs break. A new technique developed at Cardiff University allows scientists to examine DNA damage across all 28,000 human genes for the first time, providing an unprecedented view of damage that can lead to cancer. This novel technology will have implications for cancer risk assessment, diagnostics, and developing new therapeutics.
The document discusses two studies related to protein synthesis and cancer. The first study developed a new method to selectively silence genes encoding proteins to determine their function in tumor cells. The second study identified the protein components responsible for inserting membrane proteins, resolving a mechanism that was previously unknown. Understanding protein functions and interactions is important for gaining insights into the origins of cancer and developing prevention and treatment strategies.
The document discusses several studies related to DNA and cancer. A study identified a gene, NFIB, that is overexpressed in mouse and human lung tumors and appears to drive progression of small cell lung cancer. Another study revealed the molecular mechanism that promotes cancer development by characterizing regions of DNA that are more susceptible to breakage in early cancer development. A third study identified the molecular basis for DNA breakage in cancer cells.
The document summarizes two scientific studies. The first study reveals the molecular mechanism of how a crucial enzyme processes DNA during replication, indicating potential ways to block uncontrolled cell division. The second study found that neurodegeneration can be caused by a mutation in a gene encoding an important protein for neurological translation, and identified another missing protein involved in the disease. Both studies provide new insights into genetic mechanisms that could help advance medical understanding and treatments of diseases like cancer and neurological disorders.
Researchers at the UT Southwestern Medical Center and the University of Geneva studied how certain genes and proteins involved in maintaining genetic stability can sometimes contribute to cancer development. They found:
1) Mutations in the p53 tumor suppressor gene, which normally restrains mobile genetic elements, were prevalent in cancer samples. This leads to genomic instability by allowing increased movement of these elements within chromosomes.
2) The APOBEC protein, intended to fight viruses by modifying single-stranded DNA, can exploit weaknesses during human DNA replication to introduce mutations, as detected in tumor cells. It acts on the single strands present during replication fork separation.
3) Understanding how p53 and APOBEC influence genetic
The document discusses two studies on the causes of cancer at the chromosomal and DNA level. The first study found that dramatic structural changes to chromosomes could not be explained by standard models of DNA damage and were a major cause of cancer proliferation. The second study discovered the overexpression of repetitive satellite DNA sequences in common tumor cells that are normally found in heterochromatin and centromeres. Understanding the molecular causes of diseases like cancer will enable early diagnosis, new therapeutic targets, and improved treatment strategies.
The Evolution of In Situ Genetic Technologyasclepiuspdfs
In situ genetic technology was historically developed and mainly focused on detection purpose, allowing specific nucleic acid sequences to be visualized in morphologically preserved tissue sections. With the synergy of genetics and immunohistochemistry, in situ detection can correlate microscopic topological information with gene activity at the transcriptional or post-transcriptional levels in specific tissues. Furthermore, its resolution allows spatial distribution of nucleic acid products to be revealed in a heterogeneous cell population. The newest member to the franchise of in situ genetic technology is a direct-on-specimen enrichment methodology specifically for cell-free DNA liquid biopsy. Contrary to in situ detection, this in-well in situ innovation tackles the very first sample preparation step to reduce material loss, thereby improving overall sensitivity. Genomic nucleic acids purified from specimens have been proven to be time consuming and suffered from damages and losses; the evolution of in situ genetic technology offers a powerful tool for precision functional genomics, enabling cross-check between in vitro and in vivo findings. It further opens the door to ultimate genetic engineering in situ.
Recombination sequences in DNA may help determine the order of genes on chromosomes. This allows estimation of relative distances between genes and localization of genes. A study genotyped nearly 700,000 markers in the genomes of about 9,000 individuals to identify genes associated with polycystic ovary syndrome (PCOS). The study did not find genes regulating testosterone production in the ovaries, which was previously thought to be a major factor in PCOS. Another study mapped gene activity in the first few days of human embryo development from fertilization to provide insight into the "ignition key" that switches on human development.
Unlocking The Secrets Of DNA And First View Of DNA Damage Within Entire Human...Isabella Cano
Neutron scattering can provide information about the correlation between DNA base pairs during denaturation, which is not possible using other techniques. The experiment measured the first stage of the melting transition where DNA strands separate as the bonds between base pairs break. A new technique developed at Cardiff University allows scientists to examine DNA damage across all 28,000 human genes for the first time, providing an unprecedented view of damage that can lead to cancer. This novel technology will have implications for cancer risk assessment, diagnostics, and developing new therapeutics.
The document discusses two studies related to protein synthesis and cancer. The first study developed a new method to selectively silence genes encoding proteins to determine their function in tumor cells. The second study identified the protein components responsible for inserting membrane proteins, resolving a mechanism that was previously unknown. Understanding protein functions and interactions is important for gaining insights into the origins of cancer and developing prevention and treatment strategies.
The document discusses several studies related to DNA and cancer. A study identified a gene, NFIB, that is overexpressed in mouse and human lung tumors and appears to drive progression of small cell lung cancer. Another study revealed the molecular mechanism that promotes cancer development by characterizing regions of DNA that are more susceptible to breakage in early cancer development. A third study identified the molecular basis for DNA breakage in cancer cells.
The document summarizes two scientific studies. The first study reveals the molecular mechanism of how a crucial enzyme processes DNA during replication, indicating potential ways to block uncontrolled cell division. The second study found that neurodegeneration can be caused by a mutation in a gene encoding an important protein for neurological translation, and identified another missing protein involved in the disease. Both studies provide new insights into genetic mechanisms that could help advance medical understanding and treatments of diseases like cancer and neurological disorders.
Researchers at the UT Southwestern Medical Center and the University of Geneva studied how certain genes and proteins involved in maintaining genetic stability can sometimes contribute to cancer development. They found:
1) Mutations in the p53 tumor suppressor gene, which normally restrains mobile genetic elements, were prevalent in cancer samples. This leads to genomic instability by allowing increased movement of these elements within chromosomes.
2) The APOBEC protein, intended to fight viruses by modifying single-stranded DNA, can exploit weaknesses during human DNA replication to introduce mutations, as detected in tumor cells. It acts on the single strands present during replication fork separation.
3) Understanding how p53 and APOBEC influence genetic
The document discusses two studies on the causes of cancer at the chromosomal and DNA level. The first study found that dramatic structural changes to chromosomes could not be explained by standard models of DNA damage and were a major cause of cancer proliferation. The second study discovered the overexpression of repetitive satellite DNA sequences in common tumor cells that are normally found in heterochromatin and centromeres. Understanding the molecular causes of diseases like cancer will enable early diagnosis, new therapeutic targets, and improved treatment strategies.
The Evolution of In Situ Genetic Technologyasclepiuspdfs
In situ genetic technology was historically developed and mainly focused on detection purpose, allowing specific nucleic acid sequences to be visualized in morphologically preserved tissue sections. With the synergy of genetics and immunohistochemistry, in situ detection can correlate microscopic topological information with gene activity at the transcriptional or post-transcriptional levels in specific tissues. Furthermore, its resolution allows spatial distribution of nucleic acid products to be revealed in a heterogeneous cell population. The newest member to the franchise of in situ genetic technology is a direct-on-specimen enrichment methodology specifically for cell-free DNA liquid biopsy. Contrary to in situ detection, this in-well in situ innovation tackles the very first sample preparation step to reduce material loss, thereby improving overall sensitivity. Genomic nucleic acids purified from specimens have been proven to be time consuming and suffered from damages and losses; the evolution of in situ genetic technology offers a powerful tool for precision functional genomics, enabling cross-check between in vitro and in vivo findings. It further opens the door to ultimate genetic engineering in situ.
Recombination sequences in DNA may help determine the order of genes on chromosomes. This allows estimation of relative distances between genes and localization of genes. A study genotyped nearly 700,000 markers in the genomes of about 9,000 individuals to identify genes associated with polycystic ovary syndrome (PCOS). The study did not find genes regulating testosterone production in the ovaries, which was previously thought to be a major factor in PCOS. Another study mapped gene activity in the first few days of human embryo development from fertilization to provide insight into the "ignition key" that switches on human development.
description of functional genomics and structural genomics and the techniques involved in it and also decribing the models of forward genetics and techniques involved in it and reverse genetics and techniques involved in it
The document discusses two separate but related discoveries. The first is that researchers discovered the PARK2 gene, which links lung cancer to early-onset Parkinson's disease. This discovery could allow for more targeted therapies to prevent both lung cancer and Parkinson's. The second discovery discussed is that researchers developed a new technique for positional cloning that allows mapping the large and complex genome of maize. This new approach could enable more efficient identification and study of genes associated with human diseases. Both discoveries may contribute to future gene therapy and treatments by improving understanding of gene locations and relationships to diseases.
Bionanotechnology and its applications rita martin
Bionanotechnology combination of biotechnology and nanotechnology. Find its applications in various fields Nanotherapeutics, Gene therapy , Immunotherapy, Harmless Viruses, stem cells
Nadia Pisanti - With the recent New Genome Sequencing Technologies, Medicine and Biology are witnessing a revolution where Computer Science and Data Analysis play a crucial role. In this talk, I will give an overview of perspectives and challenges in this field.
The document outlines a strategy to improve translational research and clinical trials through more tailored and personalized approaches. It proposes combining basic research on topics like DNA repair mechanisms with biology-driven therapies and immunotherapies guided by a patient's specific biomarkers. The goal is to move beyond one-size-fits-all approaches to cancer treatment and instead target therapies based on a patient's individual cancer biology and vulnerabilities to achieve better outcomes.
This document discusses proteomics and its application in cancer research. Proteomics is the large-scale study of the structure and function of proteins, and it has been used to identify biomarkers for cancer diagnosis, prognosis, and treatment prediction. By analyzing differentially expressed proteins in cancer tissues and bodily fluids, proteomics can provide insights into cancer development and new targets for therapeutic development. The document outlines several areas of focus in cancer proteomics research, including bioinformatics tools for integrated genomic and proteomic analysis, the need for high-quality biospecimens and reagents, and applications of radiolabeled monoclonal antibodies in cancer detection and therapy.
Recent developments in p53 and nano oncologytazib rahaman
Recent research into the tumor suppressor gene TP53 and its role in cancer prognosis and treatment:
1) The largest study to date of TP53 mutations in over 10,000 cancer patients across 32 cancer types found correlations between mutation types and patient survival rates, and identified 4 genes whose expression levels are associated with prognosis.
2) Additional research suggests that the PBRM1 gene, which is often mutated in kidney cancer, interacts with TP53, indicating TP53 may play a more important role in kidney cancer than previously believed.
3) A research team received $1.8 million in funding to develop new ovarian cancer therapies targeting TP53 by reactivating its function and investigating its role in cancer development
Single-cell molecular biology is a relatively new scientific field that analyzes individual cells. Early single-cell analyses characterized mitochondrial DNA, while current research focuses on quantitative analysis of gene expression through real-time RT-PCR of mRNA from single cells. This allows comparison of gene expression between individual cells, which is important given tissue heterogeneity. Polymerase chain reaction (PCR) amplification enables analysis of DNA from single cells, with applications including disease mechanism elucidation by comparing gene expression profiles in healthy and diseased cells, stem cell research, metagenomics, prenatal genetic testing, and early cancer detection. However, single-cell PCR is technically challenging due to working with small amounts of genetic material.
Scientists have discovered seven new DNA regions that are linked to an increased risk of prostate cancer. A study of prostate cancer patients found variants in these DNA regions that are associated with carcinogenesis. This discovery may help explain the 25% risk of familial prostate cancer. Identifying the specific genes and DNA regions involved in prostate cancer risk could allow for new prevention techniques.
This document summarizes a mini symposium discussing the integration of transcriptomics and proteomics. It includes three presentations: 1) Cancer Proteogenomics by Prof. David Fenyö discussing novel approaches for tumor proteogenomics and biomarker identification. 2) Protein identification based on ribosome targeted mRNA fragments by Dr. Gerben Menschaert discussing integrating ribosome profiling and mass spectrometry to provide information on protein synthesis. 3) Improved MS/MS peptide identification through Machine Learning by Dr. Sven Degroeve showing how machine learning can use peak intensity information in MS2 spectra to improve peptide identification sensitivity and accuracy.
This document discusses the central dogma of genetics, how DNA is replicated and transcribed into RNA which is then translated into protein. It also discusses how mutations in genes can cause cancer and be inherited. Scientists found that inherited susceptibility to bowel cancer was common among patients with a family history of the disease. Retroviruses can incorporate their RNA genome into host cell DNA using reverse transcriptase. Endogenous retroviruses make up around 5% of human DNA and may play a role in brain cell development and function. Understanding genetic mutations could help develop new cancer therapies like gene editing. Retroviruses may also be used in the future for gene therapy and cancer prevention.
DNA is a long polymer of simple units called nucleotides. Each one contains a phosphate group (acid component), a sugar group (neutral component) and a nitrogen base (basic component).
This document discusses genetic mapping and its various medical applications. It describes how genetic mapping is used to identify the positions of genes within genomes and locate genes associated with certain traits or diseases. Specifically, it mentions two studies: one that used genetic mapping in mice to identify the pituitary tumor transforming gene's role in liver fibrosis, and another that mapped genes responsible for leaf rust resistance in wheat. The document also outlines some of genetic mapping's utility in medical fields like assessing disease predispositions, genetically engineering crop resistance, and examining fetal genetics during high-risk pregnancies.
This document discusses two scientific articles about cellular processes and potential applications to cancer treatment. The first article describes how a newly identified protease, Wss1, can chop down the protein components of DNA-protein crosslinks, allowing cells to replicate their genome. The second article discusses how DNA origami was used to test the effects of ephrin placement on the EphA2 receptor in cancer cells, finding it reduced invasiveness. The document concludes that further research using specialized techniques can improve understanding of disease pathophysiology and lead to potential cures in the future.
Next generation sequencing was used to determine the inheritance pattern and risk of recurrence for two brothers with intellectual disability and autism features. Exome sequencing revealed an autosomal recessive trait, meaning their sister is a carrier but healthy brother is not, so there is a risk of recurrence in the family. Clinical testing including genetic panels, biochemical tests, and chromosome microarray had all been normal. Exome sequencing allowed clinicians to determine the mode of inheritance and risk level for family members.
The document summarizes a seminar about the relationship between stem cells and brain tumors. The seminar discussed that stem cells are found in bone marrow and can generate mature cells, and that there are different types of aggressive brain tumors. It was explained that cancer stem cells are resistant to chemotherapy and need microRNAs to be killed, as microRNAs can regulate genes involved in cancer and help distinguish cancerous from non-cancerous tissue. The seminar inspired the author by showing scientific progress and the presenter's passion for research.
Genetic mapping is used to determine the specific location of genes on chromosomes. Knowing gene locations can help identify genetic diseases and their underlying causes. One document describes how researchers used genetic techniques to identify a gene (PSR1) in algae that increases lipid production without subjecting the algae to stress. This could allow for lipid extraction and energy production while preserving the algae species. A second document discusses a new method developed by the University of Haifa to reduce the number of possible genetic effects to study from millions to thousands. The method was tested successfully in a plant with over 7,000 genes. This type of research can help identify genetic diseases more easily and determine the best treatments.
This document summarizes two genetic studies on cancer. The first study mapped genetic mutations in cutaneous melanoma and identified four subtypes. It also found a protein related to immune response that is overexpressed in melanoma cells. The second study linked a genetic variation in the FOPNL gene to poorer survival rates in multiple myeloma patients, but the mechanism is still unknown. Both studies help locate genes of interest and their variations in diseases, which can inform targeted cancer therapies and improve patient outcomes.
Scientists have discovered seven new DNA regions that are linked to an increased risk of prostate cancer. A study of prostate cancer patients found variants in these DNA regions that are associated with carcinogenesis. This discovery may help explain the 25% risk of familial prostate cancer. Identifying the specific genes influencing prostate cancer risk can lead to new prevention techniques.
The document discusses recent discoveries related to DNA and stem cells that are allowing for new therapeutic approaches to cancer management. Specifically, it discusses how discoveries of the protein MutL, which helps repair DNA errors, and how mutations in genes encoding DNA repair proteins can lead to cancers. It also discusses how researchers have identified a new stem cell signaling pathway that may help lower tumor risks in stem cell therapies by reducing formation of teratomas during stem cell differentiation.
description of functional genomics and structural genomics and the techniques involved in it and also decribing the models of forward genetics and techniques involved in it and reverse genetics and techniques involved in it
The document discusses two separate but related discoveries. The first is that researchers discovered the PARK2 gene, which links lung cancer to early-onset Parkinson's disease. This discovery could allow for more targeted therapies to prevent both lung cancer and Parkinson's. The second discovery discussed is that researchers developed a new technique for positional cloning that allows mapping the large and complex genome of maize. This new approach could enable more efficient identification and study of genes associated with human diseases. Both discoveries may contribute to future gene therapy and treatments by improving understanding of gene locations and relationships to diseases.
Bionanotechnology and its applications rita martin
Bionanotechnology combination of biotechnology and nanotechnology. Find its applications in various fields Nanotherapeutics, Gene therapy , Immunotherapy, Harmless Viruses, stem cells
Nadia Pisanti - With the recent New Genome Sequencing Technologies, Medicine and Biology are witnessing a revolution where Computer Science and Data Analysis play a crucial role. In this talk, I will give an overview of perspectives and challenges in this field.
The document outlines a strategy to improve translational research and clinical trials through more tailored and personalized approaches. It proposes combining basic research on topics like DNA repair mechanisms with biology-driven therapies and immunotherapies guided by a patient's specific biomarkers. The goal is to move beyond one-size-fits-all approaches to cancer treatment and instead target therapies based on a patient's individual cancer biology and vulnerabilities to achieve better outcomes.
This document discusses proteomics and its application in cancer research. Proteomics is the large-scale study of the structure and function of proteins, and it has been used to identify biomarkers for cancer diagnosis, prognosis, and treatment prediction. By analyzing differentially expressed proteins in cancer tissues and bodily fluids, proteomics can provide insights into cancer development and new targets for therapeutic development. The document outlines several areas of focus in cancer proteomics research, including bioinformatics tools for integrated genomic and proteomic analysis, the need for high-quality biospecimens and reagents, and applications of radiolabeled monoclonal antibodies in cancer detection and therapy.
Recent developments in p53 and nano oncologytazib rahaman
Recent research into the tumor suppressor gene TP53 and its role in cancer prognosis and treatment:
1) The largest study to date of TP53 mutations in over 10,000 cancer patients across 32 cancer types found correlations between mutation types and patient survival rates, and identified 4 genes whose expression levels are associated with prognosis.
2) Additional research suggests that the PBRM1 gene, which is often mutated in kidney cancer, interacts with TP53, indicating TP53 may play a more important role in kidney cancer than previously believed.
3) A research team received $1.8 million in funding to develop new ovarian cancer therapies targeting TP53 by reactivating its function and investigating its role in cancer development
Single-cell molecular biology is a relatively new scientific field that analyzes individual cells. Early single-cell analyses characterized mitochondrial DNA, while current research focuses on quantitative analysis of gene expression through real-time RT-PCR of mRNA from single cells. This allows comparison of gene expression between individual cells, which is important given tissue heterogeneity. Polymerase chain reaction (PCR) amplification enables analysis of DNA from single cells, with applications including disease mechanism elucidation by comparing gene expression profiles in healthy and diseased cells, stem cell research, metagenomics, prenatal genetic testing, and early cancer detection. However, single-cell PCR is technically challenging due to working with small amounts of genetic material.
Scientists have discovered seven new DNA regions that are linked to an increased risk of prostate cancer. A study of prostate cancer patients found variants in these DNA regions that are associated with carcinogenesis. This discovery may help explain the 25% risk of familial prostate cancer. Identifying the specific genes and DNA regions involved in prostate cancer risk could allow for new prevention techniques.
This document summarizes a mini symposium discussing the integration of transcriptomics and proteomics. It includes three presentations: 1) Cancer Proteogenomics by Prof. David Fenyö discussing novel approaches for tumor proteogenomics and biomarker identification. 2) Protein identification based on ribosome targeted mRNA fragments by Dr. Gerben Menschaert discussing integrating ribosome profiling and mass spectrometry to provide information on protein synthesis. 3) Improved MS/MS peptide identification through Machine Learning by Dr. Sven Degroeve showing how machine learning can use peak intensity information in MS2 spectra to improve peptide identification sensitivity and accuracy.
This document discusses the central dogma of genetics, how DNA is replicated and transcribed into RNA which is then translated into protein. It also discusses how mutations in genes can cause cancer and be inherited. Scientists found that inherited susceptibility to bowel cancer was common among patients with a family history of the disease. Retroviruses can incorporate their RNA genome into host cell DNA using reverse transcriptase. Endogenous retroviruses make up around 5% of human DNA and may play a role in brain cell development and function. Understanding genetic mutations could help develop new cancer therapies like gene editing. Retroviruses may also be used in the future for gene therapy and cancer prevention.
DNA is a long polymer of simple units called nucleotides. Each one contains a phosphate group (acid component), a sugar group (neutral component) and a nitrogen base (basic component).
This document discusses genetic mapping and its various medical applications. It describes how genetic mapping is used to identify the positions of genes within genomes and locate genes associated with certain traits or diseases. Specifically, it mentions two studies: one that used genetic mapping in mice to identify the pituitary tumor transforming gene's role in liver fibrosis, and another that mapped genes responsible for leaf rust resistance in wheat. The document also outlines some of genetic mapping's utility in medical fields like assessing disease predispositions, genetically engineering crop resistance, and examining fetal genetics during high-risk pregnancies.
This document discusses two scientific articles about cellular processes and potential applications to cancer treatment. The first article describes how a newly identified protease, Wss1, can chop down the protein components of DNA-protein crosslinks, allowing cells to replicate their genome. The second article discusses how DNA origami was used to test the effects of ephrin placement on the EphA2 receptor in cancer cells, finding it reduced invasiveness. The document concludes that further research using specialized techniques can improve understanding of disease pathophysiology and lead to potential cures in the future.
Next generation sequencing was used to determine the inheritance pattern and risk of recurrence for two brothers with intellectual disability and autism features. Exome sequencing revealed an autosomal recessive trait, meaning their sister is a carrier but healthy brother is not, so there is a risk of recurrence in the family. Clinical testing including genetic panels, biochemical tests, and chromosome microarray had all been normal. Exome sequencing allowed clinicians to determine the mode of inheritance and risk level for family members.
The document summarizes a seminar about the relationship between stem cells and brain tumors. The seminar discussed that stem cells are found in bone marrow and can generate mature cells, and that there are different types of aggressive brain tumors. It was explained that cancer stem cells are resistant to chemotherapy and need microRNAs to be killed, as microRNAs can regulate genes involved in cancer and help distinguish cancerous from non-cancerous tissue. The seminar inspired the author by showing scientific progress and the presenter's passion for research.
Genetic mapping is used to determine the specific location of genes on chromosomes. Knowing gene locations can help identify genetic diseases and their underlying causes. One document describes how researchers used genetic techniques to identify a gene (PSR1) in algae that increases lipid production without subjecting the algae to stress. This could allow for lipid extraction and energy production while preserving the algae species. A second document discusses a new method developed by the University of Haifa to reduce the number of possible genetic effects to study from millions to thousands. The method was tested successfully in a plant with over 7,000 genes. This type of research can help identify genetic diseases more easily and determine the best treatments.
This document summarizes two genetic studies on cancer. The first study mapped genetic mutations in cutaneous melanoma and identified four subtypes. It also found a protein related to immune response that is overexpressed in melanoma cells. The second study linked a genetic variation in the FOPNL gene to poorer survival rates in multiple myeloma patients, but the mechanism is still unknown. Both studies help locate genes of interest and their variations in diseases, which can inform targeted cancer therapies and improve patient outcomes.
Scientists have discovered seven new DNA regions that are linked to an increased risk of prostate cancer. A study of prostate cancer patients found variants in these DNA regions that are associated with carcinogenesis. This discovery may help explain the 25% risk of familial prostate cancer. Identifying the specific genes influencing prostate cancer risk can lead to new prevention techniques.
The document discusses recent discoveries related to DNA and stem cells that are allowing for new therapeutic approaches to cancer management. Specifically, it discusses how discoveries of the protein MutL, which helps repair DNA errors, and how mutations in genes encoding DNA repair proteins can lead to cancers. It also discusses how researchers have identified a new stem cell signaling pathway that may help lower tumor risks in stem cell therapies by reducing formation of teratomas during stem cell differentiation.
The document discusses two recent studies on nuclear transport and its implications for medical research. The first study used high-speed atomic force microscopy to visualize the dynamics of nuclear pores in colon cancer cells at nanoscale resolution. It found that nuclear pore deformation may be involved in cancer cell death. The second study identified a potential way to prevent mRNA with disease-causing mutations from leaving the nucleus in motor neuron disease. Advances in understanding nuclear transport could lead to new treatment approaches for diseases like cancer and amyotrophic lateral sclerosis.
This document summarizes and reviews two medical news articles about recent research on DNA damage and repair. The first study found that cancer cells may simplify their genomes to proliferate more easily, making the cells more vulnerable to DNA-damaging drugs. The second mapped the specific locations in the genome where cigarette smoking causes DNA damage, providing insights to help prevent and treat smoking-related lung cancer. The student concludes that further investigating DNA repair and damage mechanisms could reveal new treatment strategies and advance the understanding and prevention of diseases like cancer.
The document discusses two scientific articles about discoveries linking metabolism and gene regulation. The first found that the enzyme pyruvate dehydrogenase complex, which normally resides in mitochondria, can also enter the nucleus and generate acetyl-CoA to acetylate histones and regulate DNA replication and expression. The second discovered a protein, TARBP2, that promotes cancer metastasis but also inhibits genes linked to neurodegeneration by binding to mRNA. This reveals connections between cancer and neurodegenerative diseases. Further research on these newly discovered mechanisms could lead to new treatment and prevention strategies through genetic therapy.
The document discusses several topics related to DNA replication and repair:
1) A study found that faulty proteins involved in DNA repair may be linked to ovarian cancer recurrence and response to PARP inhibitor drugs.
2) PARP inhibitors are being tested for ovarian cancer patients with BRCA1/BRCA2 mutations or other damaged DNA repair proteins.
3) Research is exploring an earlier genetic molecule called TNA that may have preceded DNA and RNA due to its simpler structure and ability to self-replicate, providing insights into the origins of life.
4) Understanding DNA repair mechanisms and how they relate to disease could help develop new treatments, such as genomic therapies that insert missing genes.
The document discusses recent discoveries in DNA and stem cells that are enabling new cancer treatments. It describes how the protein MutL helps repair DNA errors, and how this relates to hereditary cancers. It also discusses how stem cell research is helping understand tumor risk from stem cell therapies by identifying pathways for stem cell self-propagation and differentiation. The discoveries provide opportunities to develop targeted cancer therapies and better understand genetic diseases and stem cell behavior.
Researchers discovered a protein involved in cancer metastasis that also inhibits two proteins linked to neurodegenerative diseases. They also identified a non-coding RNA called INXS that modulates a gene important for apoptosis. In mouse studies, tumors treated with INXS decreased in size compared to controls. Both studies could help develop future cancer treatments by inhibiting metastasis genes or activating apoptosis through increasing INXS expression.
This document is a PhD thesis that examines molecular profiling of endometriosis and related malignancies. It includes 3 studies on this topic. The first study profiles miRNA expression in endometriosis and ovarian cancer samples to identify differently expressed miRNAs and generate miRNA networks. The second study examines the effects of caffeic acid phenethyl ester on ovarian cancer cells and related gene expression. The third study explores the therapeutic potential of RNA interference for modulating gene expression in ovarian and cervical cancers. The thesis aims to further the understanding of molecular mechanisms in endometriosis and related cancers to inform diagnostic and treatment approaches.
This document discusses the central dogma of genetics, how DNA is replicated and transcribed into RNA which is then translated into protein. It also discusses how mutated genes can cause cancer and be inherited. Studies found that inherited susceptibility to bowel cancer is common in families with a history of the disease, suggesting wider genetic testing. Retroviruses can integrate their RNA genome into host DNA using reverse transcriptase. Endogenous retroviruses make up about 5% of human DNA and may have played an important role in brain development and function over evolution. Retroviruses could potentially be used in gene therapy applications.
Defective Telomeres Linked To Diseases And Cancertelomerescience
The document discusses two medical research studies. The first study investigates telomeres, the protective structures at the end of chromosomes, and finds defective telomeres are linked to diseases like cancer. The second describes a new more efficient method for making RNA molecules using robotics that could speed up research exponentially. The student observes both studies have important clinical applications, with telomeres key to future cancer research and the new RNA technique allowing diagnostics and therapeutics.
Defective telomeres linked to diseases and cancerpipeg19
The document discusses two medical research studies. The first study investigates telomeres, the protective structures at the end of chromosomes, and finds defective telomeres are linked to diseases like cancer. The second describes a new efficient method for making RNA molecules using robotics that could speed up research exponentially. The student observes both studies have important clinical applications, with telomeres key to future cancer therapy and the new RNA technique allowing diagnostics and therapeutics.
Pegable Biología Molecular. María Alejandra Gómez Otálvaro95242014
Scientists have identified two key DNA repair methods. UvrD facilitates repair by pulling RNA polymerase backwards to expose DNA lesions. The Mre11 complex cuts DNA strands to initiate precise homologous recombination repair. Defects in related human proteins XPB and Mre11 have been linked to diseases like xeroderma pigmentosum and cancer. Further research on these repair proteins may help develop new therapies.
The document discusses two scientific studies investigating methods to inhibit DNA replication:
1) A 2017 study found that the bacterial toxin yatakemycin prevents DNA replication by forming strong bonds between DNA strands. This could potentially treat cancers and illnesses.
2) A second 2017 study identified a new antibiotic, closthioamide, that shows promise in treating gonorrhea. It inhibits DNA gyrase to block replication in Neisseria gonorrhoeae bacteria. Both studies explore new approaches to targeting DNA replication that could expand treatment options.
New Insight Into the Human Genome Through the Lens of Evolution and decode M...Christian Sanchez Valencia
DNA contains the genetic blueprint for human life. It can be used to diagnose diseases by comparing DNA sequences between past and present humans. DNA is transcribed into RNA, some of which encodes proteins and some that performs regulatory functions by determining gene expression. Scientists have discovered that up to 30% of human DNA is conserved at the RNA structure level through a process called transcription. Understanding how RNA is regulated through interactions with proteins and sequences is important for identifying patterns involved in diseases and their treatment.
The document discusses the importance of DNA replication for life and medicine. DNA replication is essential for cell division and is targeted by chemotherapy drugs to stop the growth of cancer cells. Understanding DNA replication better through research could help develop preventative treatments for diseases and improve medical knowledge.
The mechanisms of DNA repair help us maintain the body in a normal physiological state, despite of the constant inducing damage that we are exposed.
But if these repair mechanisms fail for some reason it could cause mutations, cell death and many diseases.
Therefore, a low mutation rate indicates the efficiency of repair mechanisms, but a failure of these will be the cause of several mutations.
Several studies point to the discovery of new mechanisms of repair, so try to create treatments for diseases.
This document discusses using gold nanoparticles for breast cancer gene therapy. It provides background on breast cancer, gene therapy, and nanoparticles. It describes how gold nanoparticles can be used to deliver tumor suppressor genes or siRNA to cancer cells via gene therapy to treat breast cancer. Gold nanoparticles are promising for cancer therapy due to their ability to bind drugs and proteins and target cancer cells. The document envisions future prospects for improving siRNA delivery and developing multifunctional gold nanoparticles for combined imaging and targeted drug/gene delivery to treat breast cancer.
The document discusses two papers: "DNA Technology and Evolution of the Central Dogma" and "The Shape of Infectious Prions". It summarizes the key points of each paper. For the first paper, it describes how DNA sequencing has accelerated techniques like nanopore sequencing and complex DNA synthesis, contributing to understanding of genomes and wildlife ecosystems. For the second paper, it explains that prions have a normal spherical shape but an infected cubic shape, and can induce normal prion proteins to acquire an abnormal conformation, causing incurable neurodegenerative diseases. The student observes that these studies will help develop new drugs for serious diseases.
Nanotechnology and potential in Cancer therapy and treatmentladen12
this presentation focuses on new nanotechnology and it possible use in detection and therapy with cancer. it was prepared by final year biochemistry student at NCU.
Similar to Researchers use DNA strands to build decomposable nano structures and where does the pathological misfolding of the prion originate? (20)
5th LF Energy Power Grid Model Meet-up SlidesDanBrown980551
5th Power Grid Model Meet-up
It is with great pleasure that we extend to you an invitation to the 5th Power Grid Model Meet-up, scheduled for 6th June 2024. This event will adopt a hybrid format, allowing participants to join us either through an online Mircosoft Teams session or in person at TU/e located at Den Dolech 2, Eindhoven, Netherlands. The meet-up will be hosted by Eindhoven University of Technology (TU/e), a research university specializing in engineering science & technology.
Power Grid Model
The global energy transition is placing new and unprecedented demands on Distribution System Operators (DSOs). Alongside upgrades to grid capacity, processes such as digitization, capacity optimization, and congestion management are becoming vital for delivering reliable services.
Power Grid Model is an open source project from Linux Foundation Energy and provides a calculation engine that is increasingly essential for DSOs. It offers a standards-based foundation enabling real-time power systems analysis, simulations of electrical power grids, and sophisticated what-if analysis. In addition, it enables in-depth studies and analysis of the electrical power grid’s behavior and performance. This comprehensive model incorporates essential factors such as power generation capacity, electrical losses, voltage levels, power flows, and system stability.
Power Grid Model is currently being applied in a wide variety of use cases, including grid planning, expansion, reliability, and congestion studies. It can also help in analyzing the impact of renewable energy integration, assessing the effects of disturbances or faults, and developing strategies for grid control and optimization.
What to expect
For the upcoming meetup we are organizing, we have an exciting lineup of activities planned:
-Insightful presentations covering two practical applications of the Power Grid Model.
-An update on the latest advancements in Power Grid -Model technology during the first and second quarters of 2024.
-An interactive brainstorming session to discuss and propose new feature requests.
-An opportunity to connect with fellow Power Grid Model enthusiasts and users.
Taking AI to the Next Level in Manufacturing.pdfssuserfac0301
Read Taking AI to the Next Level in Manufacturing to gain insights on AI adoption in the manufacturing industry, such as:
1. How quickly AI is being implemented in manufacturing.
2. Which barriers stand in the way of AI adoption.
3. How data quality and governance form the backbone of AI.
4. Organizational processes and structures that may inhibit effective AI adoption.
6. Ideas and approaches to help build your organization's AI strategy.
Monitoring and Managing Anomaly Detection on OpenShift.pdfTosin Akinosho
Monitoring and Managing Anomaly Detection on OpenShift
Overview
Dive into the world of anomaly detection on edge devices with our comprehensive hands-on tutorial. This SlideShare presentation will guide you through the entire process, from data collection and model training to edge deployment and real-time monitoring. Perfect for those looking to implement robust anomaly detection systems on resource-constrained IoT/edge devices.
Key Topics Covered
1. Introduction to Anomaly Detection
- Understand the fundamentals of anomaly detection and its importance in identifying unusual behavior or failures in systems.
2. Understanding Edge (IoT)
- Learn about edge computing and IoT, and how they enable real-time data processing and decision-making at the source.
3. What is ArgoCD?
- Discover ArgoCD, a declarative, GitOps continuous delivery tool for Kubernetes, and its role in deploying applications on edge devices.
4. Deployment Using ArgoCD for Edge Devices
- Step-by-step guide on deploying anomaly detection models on edge devices using ArgoCD.
5. Introduction to Apache Kafka and S3
- Explore Apache Kafka for real-time data streaming and Amazon S3 for scalable storage solutions.
6. Viewing Kafka Messages in the Data Lake
- Learn how to view and analyze Kafka messages stored in a data lake for better insights.
7. What is Prometheus?
- Get to know Prometheus, an open-source monitoring and alerting toolkit, and its application in monitoring edge devices.
8. Monitoring Application Metrics with Prometheus
- Detailed instructions on setting up Prometheus to monitor the performance and health of your anomaly detection system.
9. What is Camel K?
- Introduction to Camel K, a lightweight integration framework built on Apache Camel, designed for Kubernetes.
10. Configuring Camel K Integrations for Data Pipelines
- Learn how to configure Camel K for seamless data pipeline integrations in your anomaly detection workflow.
11. What is a Jupyter Notebook?
- Overview of Jupyter Notebooks, an open-source web application for creating and sharing documents with live code, equations, visualizations, and narrative text.
12. Jupyter Notebooks with Code Examples
- Hands-on examples and code snippets in Jupyter Notebooks to help you implement and test anomaly detection models.
Digital Marketing Trends in 2024 | Guide for Staying AheadWask
https://www.wask.co/ebooks/digital-marketing-trends-in-2024
Feeling lost in the digital marketing whirlwind of 2024? Technology is changing, consumer habits are evolving, and staying ahead of the curve feels like a never-ending pursuit. This e-book is your compass. Dive into actionable insights to handle the complexities of modern marketing. From hyper-personalization to the power of user-generated content, learn how to build long-term relationships with your audience and unlock the secrets to success in the ever-shifting digital landscape.
Driving Business Innovation: Latest Generative AI Advancements & Success StorySafe Software
Are you ready to revolutionize how you handle data? Join us for a webinar where we’ll bring you up to speed with the latest advancements in Generative AI technology and discover how leveraging FME with tools from giants like Google Gemini, Amazon, and Microsoft OpenAI can supercharge your workflow efficiency.
During the hour, we’ll take you through:
Guest Speaker Segment with Hannah Barrington: Dive into the world of dynamic real estate marketing with Hannah, the Marketing Manager at Workspace Group. Hear firsthand how their team generates engaging descriptions for thousands of office units by integrating diverse data sources—from PDF floorplans to web pages—using FME transformers, like OpenAIVisionConnector and AnthropicVisionConnector. This use case will show you how GenAI can streamline content creation for marketing across the board.
Ollama Use Case: Learn how Scenario Specialist Dmitri Bagh has utilized Ollama within FME to input data, create custom models, and enhance security protocols. This segment will include demos to illustrate the full capabilities of FME in AI-driven processes.
Custom AI Models: Discover how to leverage FME to build personalized AI models using your data. Whether it’s populating a model with local data for added security or integrating public AI tools, find out how FME facilitates a versatile and secure approach to AI.
We’ll wrap up with a live Q&A session where you can engage with our experts on your specific use cases, and learn more about optimizing your data workflows with AI.
This webinar is ideal for professionals seeking to harness the power of AI within their data management systems while ensuring high levels of customization and security. Whether you're a novice or an expert, gain actionable insights and strategies to elevate your data processes. Join us to see how FME and AI can revolutionize how you work with data!
Skybuffer SAM4U tool for SAP license adoptionTatiana Kojar
Manage and optimize your license adoption and consumption with SAM4U, an SAP free customer software asset management tool.
SAM4U, an SAP complimentary software asset management tool for customers, delivers a detailed and well-structured overview of license inventory and usage with a user-friendly interface. We offer a hosted, cost-effective, and performance-optimized SAM4U setup in the Skybuffer Cloud environment. You retain ownership of the system and data, while we manage the ABAP 7.58 infrastructure, ensuring fixed Total Cost of Ownership (TCO) and exceptional services through the SAP Fiori interface.
Main news related to the CCS TSI 2023 (2023/1695)Jakub Marek
An English 🇬🇧 translation of a presentation to the speech I gave about the main changes brought by CCS TSI 2023 at the biggest Czech conference on Communications and signalling systems on Railways, which was held in Clarion Hotel Olomouc from 7th to 9th November 2023 (konferenceszt.cz). Attended by around 500 participants and 200 on-line followers.
The original Czech 🇨🇿 version of the presentation can be found here: https://www.slideshare.net/slideshow/hlavni-novinky-souvisejici-s-ccs-tsi-2023-2023-1695/269688092 .
The videorecording (in Czech) from the presentation is available here: https://youtu.be/WzjJWm4IyPk?si=SImb06tuXGb30BEH .
Fueling AI with Great Data with Airbyte WebinarZilliz
This talk will focus on how to collect data from a variety of sources, leveraging this data for RAG and other GenAI use cases, and finally charting your course to productionalization.
Skybuffer AI: Advanced Conversational and Generative AI Solution on SAP Busin...Tatiana Kojar
Skybuffer AI, built on the robust SAP Business Technology Platform (SAP BTP), is the latest and most advanced version of our AI development, reaffirming our commitment to delivering top-tier AI solutions. Skybuffer AI harnesses all the innovative capabilities of the SAP BTP in the AI domain, from Conversational AI to cutting-edge Generative AI and Retrieval-Augmented Generation (RAG). It also helps SAP customers safeguard their investments into SAP Conversational AI and ensure a seamless, one-click transition to SAP Business AI.
With Skybuffer AI, various AI models can be integrated into a single communication channel such as Microsoft Teams. This integration empowers business users with insights drawn from SAP backend systems, enterprise documents, and the expansive knowledge of Generative AI. And the best part of it is that it is all managed through our intuitive no-code Action Server interface, requiring no extensive coding knowledge and making the advanced AI accessible to more users.
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfChart Kalyan
A Mix Chart displays historical data of numbers in a graphical or tabular form. The Kalyan Rajdhani Mix Chart specifically shows the results of a sequence of numbers over different periods.
Have you ever been confused by the myriad of choices offered by AWS for hosting a website or an API?
Lambda, Elastic Beanstalk, Lightsail, Amplify, S3 (and more!) can each host websites + APIs. But which one should we choose?
Which one is cheapest? Which one is fastest? Which one will scale to meet our needs?
Join me in this session as we dive into each AWS hosting service to determine which one is best for your scenario and explain why!
Introduction of Cybersecurity with OSS at Code Europe 2024Hiroshi SHIBATA
I develop the Ruby programming language, RubyGems, and Bundler, which are package managers for Ruby. Today, I will introduce how to enhance the security of your application using open-source software (OSS) examples from Ruby and RubyGems.
The first topic is CVE (Common Vulnerabilities and Exposures). I have published CVEs many times. But what exactly is a CVE? I'll provide a basic understanding of CVEs and explain how to detect and handle vulnerabilities in OSS.
Next, let's discuss package managers. Package managers play a critical role in the OSS ecosystem. I'll explain how to manage library dependencies in your application.
I'll share insights into how the Ruby and RubyGems core team works to keep our ecosystem safe. By the end of this talk, you'll have a better understanding of how to safeguard your code.
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-und-domino-lizenzkostenreduzierung-in-der-welt-von-dlau/
DLAU und die Lizenzen nach dem CCB- und CCX-Modell sind für viele in der HCL-Community seit letztem Jahr ein heißes Thema. Als Notes- oder Domino-Kunde haben Sie vielleicht mit unerwartet hohen Benutzerzahlen und Lizenzgebühren zu kämpfen. Sie fragen sich vielleicht, wie diese neue Art der Lizenzierung funktioniert und welchen Nutzen sie Ihnen bringt. Vor allem wollen Sie sicherlich Ihr Budget einhalten und Kosten sparen, wo immer möglich. Das verstehen wir und wir möchten Ihnen dabei helfen!
Wir erklären Ihnen, wie Sie häufige Konfigurationsprobleme lösen können, die dazu führen können, dass mehr Benutzer gezählt werden als nötig, und wie Sie überflüssige oder ungenutzte Konten identifizieren und entfernen können, um Geld zu sparen. Es gibt auch einige Ansätze, die zu unnötigen Ausgaben führen können, z. B. wenn ein Personendokument anstelle eines Mail-Ins für geteilte Mailboxen verwendet wird. Wir zeigen Ihnen solche Fälle und deren Lösungen. Und natürlich erklären wir Ihnen das neue Lizenzmodell.
Nehmen Sie an diesem Webinar teil, bei dem HCL-Ambassador Marc Thomas und Gastredner Franz Walder Ihnen diese neue Welt näherbringen. Es vermittelt Ihnen die Tools und das Know-how, um den Überblick zu bewahren. Sie werden in der Lage sein, Ihre Kosten durch eine optimierte Domino-Konfiguration zu reduzieren und auch in Zukunft gering zu halten.
Diese Themen werden behandelt
- Reduzierung der Lizenzkosten durch Auffinden und Beheben von Fehlkonfigurationen und überflüssigen Konten
- Wie funktionieren CCB- und CCX-Lizenzen wirklich?
- Verstehen des DLAU-Tools und wie man es am besten nutzt
- Tipps für häufige Problembereiche, wie z. B. Team-Postfächer, Funktions-/Testbenutzer usw.
- Praxisbeispiele und Best Practices zum sofortigen Umsetzen
Letter and Document Automation for Bonterra Impact Management (fka Social Sol...Jeffrey Haguewood
Sidekick Solutions uses Bonterra Impact Management (fka Social Solutions Apricot) and automation solutions to integrate data for business workflows.
We believe integration and automation are essential to user experience and the promise of efficient work through technology. Automation is the critical ingredient to realizing that full vision. We develop integration products and services for Bonterra Case Management software to support the deployment of automations for a variety of use cases.
This video focuses on automated letter generation for Bonterra Impact Management using Google Workspace or Microsoft 365.
Interested in deploying letter generation automations for Bonterra Impact Management? Contact us at sales@sidekicksolutionsllc.com to discuss next steps.
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slackshyamraj55
Discover the seamless integration of RPA (Robotic Process Automation), COMPOSER, and APM with AWS IDP enhanced with Slack notifications. Explore how these technologies converge to streamline workflows, optimize performance, and ensure secure access, all while leveraging the power of AWS IDP and real-time communication via Slack notifications.
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Researchers use DNA strands to build decomposable nano structures and where does the pathological misfolding of the prion originate?
1. Researchers use DNA strands to build
decomposable nanostructures and where
does the pathological misfolding of the
prion originate?
Laura Arango Gutiérrez
Medical Student
4. A clear example of what I want to
explain is cancer because of its
characteristic excess in cell growth due
to damages in the control mechanisms
of the cell during its cycle.
For that reason , cancer treatments are
designed to affect DNA, RNA and
proteins so as to stop the pathological
process of the cell cycle
5. Some years researchers found
the use of nanostructures
build from nanoparticles as a
method to deliver drug
directly to the tumor, killing it
6. Researchers use DNA strands to
build decomposable nanostructures
But there was a problem: the
materials of nanostructures
are considered toxic if they
build up in the body and the
structures are too big for the
body so it’s difficult to break
down and to remove them.
7. Researchers use DNA strands to
build decomposable nanostructures
Nanoparticles
DNA strands
The use of DNA strands to tie nanoparticles and
polymers can mediate the assembly of larger
nanostructures and control their interactions
with biological systems.
Nanoparticles tie with
DNA strands form
Nanostructures
8. Researchers use DNA strands to
build decomposable nanostructures
The researchers tested
in mice and they found
that nanoparticles were
in mouse urine,
indicating that the mice
system were able to
remove the smaller
sized nanostructures
9. Student Observation
I think the knowledges on
the subject should be
extended, thus this method
could be use in people
because the use of friendly
nanostructures with the
body results a good strategy
for the treatment of cancer
because it decreases the
secondary effects of the
cancer drugs. It implies to
improve the quality life of
patients which is a clear
objective of all scientific
advances
10. The investigation was based
on the idea that when prions
are healthy they look like tiny
spheres but when they are
malignant they look like
cubes
11. Where does the pathological misfolding
of the prion originate?
“Prions are unique infective agents –unlike viruses, bacteria,
fungi and other parasites, prions do not contain either DNA or
RNA”
In fact, prions are one of the exceptions of the central dogma of
molecular biology because they are proteins able to infect.
12. Where does the pathological misfolding
of the prion originate?
The pathological effects
of the malignant proteins
can propagate quickly
because
PrPSc
(the
pathological form of the
prion protein) can induce
to PrPc (normal prions
protein) to change its
conformation
and
convert it in diseasecausing agents.
13. Where does the pathological misfolding
of the prion originate?
To know the place where the
pathological misfolding of the
prion originate, researchers use Xrays, synthetic prion proteins and
small proteins (nanobodies) that
were used like plataforms and they
induce prions to stabilize their
structure.
With this, they found that the early prion pathological
misfolding occurs in the N-terminal subunit.
14. Student Observation
I think that this kind of
investigation represents a
major step in the sciencie
because keep researching
about the way how the prions
are modified to convert into
disease-causing agents and
find results on this topic
means find therapeuctic
stretagies against incurable
neurodegenerative diseases.
This investigation is an
example of the importance of
the molecular approach in the
study of the pathologies
15. It is very important to know
the molecular basis of the
different pathologies to find a
treatment that makes its
effect on the molecular
proccess of the cells involve in
diseases
16. Medical utility
The use of decomposable
nanostructures tie with DNA
strands could be a very
useful method in the
treatment of cancer, for
example in chemotherapies
17. Medical utility
Nanostructures act directly on
the tumor cells decreasing the
secondary effects of these
treatments.
This is very important because
the objective of scientific
advances is to improve and
impact positively on people's
lives and this research may
mean an improvement in the
quality of life of patients with
cancer.
18. Medical utility
Considering that prions are
misfolded proteins that
cause a group of incurable
neurodegenerative
diseases like spongiform
encephalopathies, the fact
of knowing the place
where the pathological
misfolding of the prion
originate will allow to
create a possible cure and
treatment
for
neurodegenerative
diseases
Spongiform encephalopathy: Mad cow disease
19. Bibliography
CHOU, L; ZAGOROVSKY, K; CHAN, W (2014, January 26) DNA assembly of
nanoparticle superstructures for controlled biological delivery and
elimination. Nature Nanotechnology (2014) Retrieved February 7, 2014
from
http://phys.org/news/2014-01-dna-strands-decomposablenanostructures.html
ABSKHARON N. N., R; GIACHIN, G; Wohlkonig, A; SOROR, S; PARDON, E.;
LEGNAME, G., et all."Probing the N-Terminal β-Sheet Conversion in the
Crystal Structure of the Human Prion Protein Bound to a Nanobody.",
Journal of the American Chemical Society 2014 136 (3), 937-944. Retrieved
February 7, 2014 from http://phys.org/news/2014-01-pathologicalmisfolding-prion.html#jCp
MARTINEZ SÁNCHEZ, Lina María. Biología molecular. 7. ed. Medellín:
UPB. Fac. de Medicina, 2012. 74-77 p.